MedPath
NMPA Approval

Diprophylline Injection

国药准字H20249517

December 1, 2024

Drug Information

二羟丙茶碱注射液

注射剂

2ml:0.3g

化学药品

December 1, 2024

Company Information

Applicant Company

安徽省芜湖市高新技术产业开发区长江南路152号

Manufacturing Company

合肥市包河工业区纬五路15号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

二羟丙茶碱注射液 - NMPA 批准文号 | MedPath